Literature DB >> 17587818

Smad4-independent TGF-beta signaling in tumor cell migration.

Klaudia Giehl1, Yukiko Imamichi, Andre Menke.   

Abstract

Transforming growth factor-beta (TGF-beta) belongs to a family of multifunctional growth factors that participates in the regulation of a variety of cellular activities. Beside induction of growth inhibition and differentiation of epithelial cells, TGF-beta has been shown to promote epithelial-mesenchymal transition in most epithelial tumors. While inhibition of epithelial cell proliferation in response to TGF-beta is mainly mediated by the well-characterized Smad pathway and subsequent inhibition of gene transcription, the molecular mechanism leading to TGF-beta-induced invasiveness and metastasis of epithelial tumors is less clear. Recent results from several groups suggest that the induction of tumorigenic activity by TGF-beta includes not only signaling by Smads, but also by Rho-GTPases and mitogen-activated protein kinases (MAP kinases). Activation of the MAP kinases extracellular signal-regulated kinases (ERK) 1 and 2 as well as c-jun N-terminal kinase (JNK) has been identified as important steps in TGF-beta-induced, Smad4-independent signal transduction in epithelial cells. Recent results identify a role of activated ERK and JNK and their association with focal complexes in TGF-beta-induced, Smad4-independent cell migration of breast carcinoma cells, and are reviewed here. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587818     DOI: 10.1159/000101313

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  23 in total

1.  MAPK inhibitors differently modulate TGF-β/Smad signaling in HepG2 cells.

Authors:  A Boye; H Kan; C Wu; Y Jiang; X Yang; S He; Y Yang
Journal:  Tumour Biol       Date:  2015-01-07

2.  Transcriptional profiling identifies functional interactions of TGF β and PPAR β/δ signaling: synergistic induction of ANGPTL4 transcription.

Authors:  Kerstin Kaddatz; Till Adhikary; Florian Finkernagel; Wolfgang Meissner; Sabine Müller-Brüsselbach; Rolf Müller
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

3.  Transforming growth factor-beta signaling leads to uPA/PAI-1 activation and metastasis: a study on human breast cancer tissues.

Authors:  D S Lang; S Marwitz; U Heilenkötter; W Schumm; O Behrens; R Simon; M Reck; E Vollmer; T Goldmann
Journal:  Pathol Oncol Res       Date:  2014-03-09       Impact factor: 3.201

Review 4.  Targeting TGF-β Signaling for Therapeutic Gain.

Authors:  Rosemary J Akhurst
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-10-03       Impact factor: 10.005

Review 5.  The role of secondary heart field in cardiac development.

Authors:  Laura A Dyer; Margaret L Kirby
Journal:  Dev Biol       Date:  2009-10-14       Impact factor: 3.582

6.  PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1.

Authors:  Ying Chen; Guanzhen Yu; Danghui Yu; Minghua Zhu
Journal:  J Exp Clin Cancer Res       Date:  2010-08-05

7.  Inhibition of TGF-β2-induced migration and epithelial-mesenchymal transition in ARPE-19 by sulforaphane.

Authors:  Yan-Bing Huang; Ping-Ping Liu; Hui Zheng; Xiu-Xia Yang; Cheng-Cheng Yang; Ye Liu; Yang Liu
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

8.  SMAD proteins control DROSHA-mediated microRNA maturation.

Authors:  Brandi N Davis; Aaron C Hilyard; Giorgio Lagna; Akiko Hata
Journal:  Nature       Date:  2008-06-11       Impact factor: 49.962

9.  Upregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Ken Yamazaki; Yohei Masugi; Kathryn Effendi; Hanako Tsujikawa; Nobuyoshi Hiraoka; Minoru Kitago; Masahiro Shinoda; Osamu Itano; Minoru Tanabe; Yuko Kitagawa; Michiie Sakamoto
Journal:  Lab Invest       Date:  2014-04-07       Impact factor: 5.662

10.  SFRP1 reduction results in an increased sensitivity to TGF-β signaling.

Authors:  Kelly J Gauger; Kerry L Chenausky; Molly E Murray; Sallie S Schneider
Journal:  BMC Cancer       Date:  2011-02-08       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.